Effect of aerobic exercise with diet on blood sugar control and cardiovascular health of male patients with type 1 and 2 diabetes mellitus

Effect of aerobic exercise with diet on blood sugar control and cardiovascular health of male patients with type 1 and 2 diabetes mellitus: A parallel group randomized control trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14894739

Enrollment

Registered

2016-04-05

Start date

2013-01-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

Participants are divided into one of two groups in a 1:1 ratio. The patients who registered first are in the intervention group. Intervention group: Participants complete a combination of 50-minute e

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Males, aged 9 years and over 2. Diagnosis of type 1 and type 2 diabetes mellitus for more than one year 3. Absence of chronic diseases such as retinopathy, neuropathy, asthma, arthritis, morbid obesity and cardiovascular disease 4. Able to attend study centre

Exclusion criteria

Exclusion criteria: 1. Aged under 9 years 2. Diabetes diagnosis for less than one year 3. Chronic diseases such as retinopathy, neuropathy, asthma, arthritis, morbid obesity and cardiovascular disease. 4. Those unable to attend the study centre

Design outcomes

Primary

Measure	Time frame
Glycemic control is assessed by measuring HbA1c and fasting blood glucose after a 12-hour fast using Dimension® RxL Max® at baseline and 12 weeks	—

Secondary

Measure	Time frame
1. Cardiovascular health is assessed at baseline and 12 weeks: 1.1. Resting heart rate is measured manually at the radial artery (number of beats in 15 seconds was multiplied by four) 1.2. Systolic and diastolic blood pressures are measured using a sphygmomanometer 1.3. Blood lipid profile is measured after a 12-hour fast using Dimension® RxL Max® 2. Body mass is measured using a weighing scale at baseline and 12 weeks 3. Body mass index is calculated using the formula mass/height2 at baseline and 1 weeks	—

Measure

Time frame

1. Cardiovascular health is assessed at baseline and 12 weeks: 1.1. Resting heart rate is measured manually at the radial artery (number of beats in 15 seconds was multiplied by four) 1.2. Systolic and diastolic blood pressures are measured using a sphygmomanometer 1.3. Blood lipid profile is measured after a 12-hour fast using Dimension® RxL Max® 2. Body mass is measured using a weighing scale at baseline and 12 weeks 3. Body mass index is calculated using the formula mass/height2 at baseline and 1 weeks

—

Countries

Saudi Arabia

Contacts

Public ContactMohammed Hamdan Hashem Mohammed

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026